Streetbeat News

Regulatory

SOBR

Trading for an unspecified asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:50 pm

SPY

Mark Spitznagel, co-founder of Universa Investments, warns of a potential market downturn despite recent highs, predicting a 'black swan event' and stagflation. He suggests hedging against market volatility using put options on broad-exposure ETFs like SPDR S&P 500 ETF Trust (SPY).

Portfolio Pulse from Aaron Bry

October 01, 2024 | 10:34 pm

AYRWF

CRLBF

CURLF

GTBIF

PLNHF

TCNNF

VRNOF

Florida's cannabis market faces challenges despite significant investments in adult-use legalization. Companies like Trulieve and Curaleaf are heavily investing, but dispensary sales have slipped due to increased competition and external factors. The market's future hinges on legislative changes and potential growth if adult-use legalization passes.

Portfolio Pulse from Nicolás Jose Rodriguez

October 01, 2024 | 10:18 pm

LIEN

Chicago Atlantic has acquired Silver Spike Investment Corp., the only SEC-approved BDC focused on cannabis lending, and will change its ticker to $LIEN. This acquisition comes at a pivotal time for the cannabis industry, with potential regulatory reforms on the horizon.

Portfolio Pulse from Rolando García

October 01, 2024 | 9:54 pm

FUTU

Futu Holdings Ltd. (NASDAQ:FUTU) shares rose after-hours as China announced additional stimulus measures, including lower mortgage rates and a swap facility to stabilize the stock market. Futu, which operates trading platforms, may benefit from increased market capital. Shares have gained over 40% in the past five days.

Portfolio Pulse from Erica Kollmann

October 01, 2024 | 9:36 pm

ATCH

AtlasClear has filed a notification with the SEC indicating a delay in filing its transition report. This could signal potential issues with financial reporting or internal processes.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:30 pm

ORGO

Organogenesis has published results from a 218-patient randomized clinical trial showing that its product, NuShield, is safe and effective for treating diabetic foot ulcers. The study demonstrated a statistically significant improvement in wound closure at 12 weeks compared to standard care. Organogenesis believes this study meets the requirements for Medicare coverage under proposed Local Coverage Determinations.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:09 pm

MYGN

Myriad Genetics announced that the United States Patent and Trademark Office (USPTO) has issued a third patent for its molecular residual disease technology, which has an early priority date. This development strengthens Myriad's intellectual property portfolio in the field.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:08 pm

ICFI

The Environmental Protection Agency (EPA) has awarded ICF International a $75 million Blanket Purchase Agreement (BPA) to provide environmental, economic, regulatory, and evaluation services for water programs over the next five years.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:06 pm

LPLA

Trading for an unspecified asset was halted at 4:00:10 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:00 pm